ArticleGene therapy2016

Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator.

M-C Chang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.